ClinicalTrials.Veeva

Menu

Benefit of a Diagnostic MRI in Case of Pathological Nipple Discharge With Normal Mammography / Ultrasound (IRM-sein)

I

Institut Bergonié

Status

Completed

Conditions

Breast Cancer

Treatments

Device: MRI

Study type

Observational

Funder types

Other

Identifiers

NCT02819362
IB2013-IRM

Details and patient eligibility

About

Benefit of MRI in pathological nipple discharge.

Enrollment

70 patients

Sex

Female

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Single pore nipple discharge neither green nor milky.
  2. Mammography (at least 2 shots, +/- centred on retro-areal) normal.
  3. Initial ultrasound: normal.
  4. Age over 18 years
  5. Female
  6. Patient affiliated to the social security scheme.
  7. Patient information and informed consent signed and dated

Exclusion criteria

Physiological milky or green discharge

Trial design

70 participants in 1 patient group

Prospective cohort - MRI
Description:
Patients with pathological nipple discharge
Treatment:
Device: MRI

Trial contacts and locations

1

Loading...

Central trial contact

Simone MATHOULIN-PELISSIER, MD,PhD; Martine BOISSERIE-LACROIX, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems